ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Want to see HK:1541 full AI Analyst Report?
Comparison Results
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.92B
-10.14
-30.61%
―
Ascletis Pharma, Inc.
HK$18.48
HK$17.48B
-9.33
158.02%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.35B
30.77
0.99%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$21.41B
73.24
279.86%
―
CStone Pharmaceuticals
HK$5.34
HK$14.67B
-15.44
222.41%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.01
HK$4.26B
459.06
-33.71%
―
Performance Comparison
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
4.42
-2.21
-33.33%
HK:1672
Ascletis Pharma, Inc.
16.90
10.32
156.84%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.10
0.22
4.51%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
52.80
40.18
318.38%
HK:2616
CStone Pharmaceuticals
9.35
6.50
228.07%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.04
-2.96
-29.60%